NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases, announced the Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a collaborative study that will be conducted by scientists from the Perelman School of Medicine at the University of Pennsylvania (Penn); Inovio Pharmaceuticals; and MedImmune, the global biologics … Continue reading NASDAQ Losers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Himax Technologies, Inc. (NASDAQ:HIMX), Blue Earth Inc. (NASDAQ:BBLU), Omeros Corporation (NASDAQ:OMER), Net Element International Inc (NASDAQ:NETE)

Hot Stock List : Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Advanced Micro Devices, Inc. (NYSE:AMD), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Consolidated Tomoka Land Co. (NYSEMKT:CTO), VeriSign, Inc. (NASDAQ:VRSN)

Vertex Pharmaceuticals (NASDAQ:VRTX) had its price objective hosited by Maxim Group from $109.00 to $117.00 in a report released on Friday. Maxim Group currently has a buy rating on the stock. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) belongs to Healthcare sector. Its net profit margin is -56.90% and weekly performance is -5.53%. On last trading day company shares ended up $101.10. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) distance from … Continue reading Hot Stock List : Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Advanced Micro Devices, Inc. (NYSE:AMD), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Consolidated Tomoka Land Co. (NYSEMKT:CTO), VeriSign, Inc. (NASDAQ:VRSN)

Inovio Pharmaceuticals (NYSE:INO) CFO Peter Kies purchased 3,960 shares of the stock in a transaction dated Thursday, October 9th. The stock was purchased at an average price of $10.10 per share, with a total value of $39,996.00. Following the acquisition, the chief financial officer now directly owns 21,388 shares in the company, valued at approximately $216,019. T Inovio Pharmaceuticals, Inc. (NASDAQ:INO) belongs to Healthcare sector. … Continue reading Active Watch List : Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Alibaba Group Holding Ltd (NYSE:BABA), Hewlett-Packard Company (NYSE:HPQ), SunEdison, Inc. (NYSE:SUNE), Navient Corporation (NASDAQ:NAVI)